Cabozantinib After Immunotherapy in Advanced Renal Cell Carcinoma. The CARE Study by the Hellenic Gu Cancer Group

Aristotelis Bamias, Michael Liontos, Ioannis Binas, Dimitra Stefanou, Kimon Tzannis, Roubini Zakopoulou, Nikolaos Dedes, Dimitrios Deligiannis, Ioanna Katsiana, Areti Mamali, Meropi Galari, Konstantina Kakogianni, Vasiliki Nikolaidou, Dimitrios C Ziogas, Napoleon Moulavasilis, Vasiliki Magoula, Efstathia Giannopoulou, Christos Christodoulou, Meletios Athanasios Dimopoulos, Michael Chrisofos

Open source

DOI: 10.2147/cmar.s597256
Published: 2026-09
Container: Cancer Management and Research
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/cmar.s597256,
  title = {Cabozantinib After Immunotherapy in Advanced Renal Cell Carcinoma. The CARE Study by the Hellenic Gu Cancer Group},
  author = {Aristotelis Bamias and Michael Liontos and Ioannis Binas and Dimitra Stefanou and Kimon Tzannis and Roubini Zakopoulou and Nikolaos Dedes and Dimitrios Deligiannis and Ioanna Katsiana and Areti Mamali and Meropi Galari and Konstantina Kakogianni and Vasiliki Nikolaidou and Dimitrios C Ziogas and Napoleon Moulavasilis and Vasiliki Magoula and Efstathia Giannopoulou and Christos Christodoulou and Meletios Athanasios Dimopoulos and Michael Chrisofos},
  year = {2026},
  journal = {Cancer Management and Research},
  doi = {10.2147/cmar.s597256},
  url = {https://doi.org/10.2147/cmar.s597256}
}

RIS

TY  - JOUR
TI  - Cabozantinib After Immunotherapy in Advanced Renal Cell Carcinoma. The CARE Study by the Hellenic Gu Cancer Group
AU  - Aristotelis Bamias
AU  - Michael Liontos
AU  - Ioannis Binas
AU  - Dimitra Stefanou
AU  - Kimon Tzannis
AU  - Roubini Zakopoulou
AU  - Nikolaos Dedes
AU  - Dimitrios Deligiannis
AU  - Ioanna Katsiana
AU  - Areti Mamali
AU  - Meropi Galari
AU  - Konstantina Kakogianni
AU  - Vasiliki Nikolaidou
AU  - Dimitrios C Ziogas
AU  - Napoleon Moulavasilis
AU  - Vasiliki Magoula
AU  - Efstathia Giannopoulou
AU  - Christos Christodoulou
AU  - Meletios Athanasios Dimopoulos
AU  - Michael Chrisofos
PY  - 2026
JO  - Cancer Management and Research
DO  - 10.2147/cmar.s597256
UR  - https://doi.org/10.2147/cmar.s597256
ER  -

APA

Bamias, A., Liontos, M., Binas, I., Stefanou, D., Tzannis, K., Zakopoulou, R., Dedes, N., Deligiannis, D., Katsiana, I., Mamali, A., Galari, M., Kakogianni, K., Nikolaidou, V., Ziogas, D. C., Moulavasilis, N., Magoula, V., Giannopoulou, E., Christodoulou, C., Dimopoulos, M. A., & Chrisofos, M. (2026). Cabozantinib After Immunotherapy in Advanced Renal Cell Carcinoma. The CARE Study by the Hellenic Gu Cancer Group. Cancer Management and Research. https://doi.org/10.2147/cmar.s597256

Source records

crossref · retrieved 2026-09-25T00:07:49.983Z